Pharma Line srl

pharmaline.org

Pharma Line srl is a pharmaceutical company focused on high quality and innovative solutions. We are engaged in the research, development and marketing of original formulations supported by strong and rigorous scientific literature. The values inspiring all of our work are excellence and innovation. We work to improve patients’ quality of life and respond to their potential needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

MERCK ENTERS COLLABORATION AND OPTION TO LICENSE AGREEMENT WITH NERVIANO MEDICAL SCIENCES TO DEVELOP NEXT-GENERATION PARP1 SELECTIVE INHIBITOR

Merck | September 22, 2022

news image

Merck, a leading science and technology company, announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. for the next-generation highly selective and brain-penetrant PARP1 inhibitor, NMS-293. NMS-293 has strong potential in combination with a wide variety of DNA-damaging agents, including systemic or targeted chemotherapy or with DNA damage response inhibitors, in numerous tumor types. NMS-293 is in early clinical development for the treatment of patients ...

Read More

Business Insights

ALIRA HEALTH EXPANDS NORTH AMERICAN CAPABILITIES WITH THE ACQUISITION OF ARTISAN HEALTHCARE CONSULTING

Alira Health and Artisan Healthcare Consulting | September 07, 2022

news image

Alira Health, a patient-centric, global health care advisory, clinical research and technology company, announced the acquisition of Artisan Healthcare Consulting, a US-based consulting firm that provides strategic insights to healthcare companies. Artisan serves 12 of the top 15 pharmaceutical companies in the US, supports the C-Suite of leading biotechnology companies, and has deep expertise in over 30 therapeutic areas. The acquisition of Artisan strengthens and extends Alira H...

Read More

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

news image

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Prnewswire | May 27, 2020

news image

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More
news image

Business Insights

MERCK ENTERS COLLABORATION AND OPTION TO LICENSE AGREEMENT WITH NERVIANO MEDICAL SCIENCES TO DEVELOP NEXT-GENERATION PARP1 SELECTIVE INHIBITOR

Merck | September 22, 2022

Merck, a leading science and technology company, announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. for the next-generation highly selective and brain-penetrant PARP1 inhibitor, NMS-293. NMS-293 has strong potential in combination with a wide variety of DNA-damaging agents, including systemic or targeted chemotherapy or with DNA damage response inhibitors, in numerous tumor types. NMS-293 is in early clinical development for the treatment of patients ...

Read More
news image

Business Insights

ALIRA HEALTH EXPANDS NORTH AMERICAN CAPABILITIES WITH THE ACQUISITION OF ARTISAN HEALTHCARE CONSULTING

Alira Health and Artisan Healthcare Consulting | September 07, 2022

Alira Health, a patient-centric, global health care advisory, clinical research and technology company, announced the acquisition of Artisan Healthcare Consulting, a US-based consulting firm that provides strategic insights to healthcare companies. Artisan serves 12 of the top 15 pharmaceutical companies in the US, supports the C-Suite of leading biotechnology companies, and has deep expertise in over 30 therapeutic areas. The acquisition of Artisan strengthens and extends Alira H...

Read More
news image

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More
news image

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Prnewswire | May 27, 2020

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More